Ulland Investment Advisors »

Charles River Laboratories shares owned by Ulland Investment Advisors

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Ulland Investment Advisors from 13F filings

Historical chart of Ulland Investment Advisors investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by Ulland Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by Ulland Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0k 6 333.33

More positions owned by Ulland Investment Advisors

NVidia Corporation Stock (NVDA)
Invesco QQQ Trust ETF Etf (QQQ)
Alphabet Stock (GOOG)
Axon Enterprise Stock (AXON)
Meta Platforms Stock (META)
UnitedHealth Group Stock (UNH)
Apple Stock (AAPL)
Amazon.com Stock (AMZN)
Vertiv Holdings Stock (VRT)
Skyline Champion Corporation Stock (SKY)
Super Micro Computer Stock (SMCI)
Alphabet Stock (GOOGL)
Visa Stock (V)
Schwab U.S. Mid-Cap ETF Etf (SCHM)
Lowe's Companies Stock (LOW)

View all positions for Ulland Investment Advisors

Top funds holding Charles River Laboratories

Vanguard Group
BlackRock
ClearBridge Advisors
T. Rowe Price Associates
Geode Capital Management
Meritage Group
Allspring Global Investments Holdings
Mackenzie Financial
Bank of America Corporation
Earnest Partners
Southpoint Capital Advisors
Marshall Wace
Franklin Resources
Sei Investments
Wells Fargo & Company

View all funds holding Charles River Laboratories